15% OFF YOUR FIRST ORDER · CODE 1stOrder
Research hub

Pinealon Peptide

Pinealon is a synthetic EDR tripeptide identified by the sequence Glu-Asp-Arg. It is characterized as a short oligopeptide and is available as a research material for laboratory investigation.

Synthetic tripeptideshort-chain peptideEDR peptidelinear tripeptide
Molecular Weight
418.40 g/mol
Molecular Formula
C15H26N6O8
CAS Number
175175-23-2
Available nowPinealon Peptide · in stock, EU dispatch
Pinealon Peptide Vial
20mg
Price range: $60.51 through $71.74View
01

What Is Pinealon Peptide?

Pinealon is a synthetic tripeptide composed of glutamic acid, aspartic acid and arginine in the sequence Glu-Asp-Arg (EDR). It is chemically classified as a short oligopeptide containing three amino acid residues connected by peptide bonds.

Pinealon is also identified in the scientific literature as the EDR peptide. Its defined three residue sequence distinguishes it from longer peptides and proteins. The term Pinealon therefore refers to the synthetic Glu-Asp-Arg tripeptide described in published scientific and chemical databases.

02

Research Overview Table

Research OverviewCurrent Status
Compound ClassSynthetic tripeptide (Glu-Asp-Arg)
Primary Research TargetNot definitively established
Published Cell StudiesAvailable
Published Animal StudiesAvailable
Controlled Human Clinical TrialsNo published controlled human clinical trials identified
Primary Research FieldNeurobiology, neuronal signaling, oxidative stress, cellular aging, and neurodegenerative research
Research MaturityPredominantly preclinical
Intended UseLaboratory research only
03

Chemical and Molecular Characteristics

Chemical NameL-alpha-glutamyl-L-alpha-aspartyl-L-arginine
Compound NamePinealon
Compound TypeSynthetic tripeptide
Molecular FormulaC₁₅H₂₆N₆O₈
Molecular Weight418.40 g/mol
PurityNot provided
CAS Number175175-23-2
Batch/Lot NumberNot provided
Primary Research TargetNot definitively established
Product Format(s)Vial
Physical PresentationWhite or almost white powder

Pinealon has a compact three-residue architecture with peptide linkages between its constituent amino acids. Its structure contains several ionizable groups, including carboxyl groups and the arginine guanidino group. These features give the molecule a strongly polar character and multiple sites for hydrogen bonding and charge-dependent interactions.

As a tripeptide, Pinealon has a much simpler molecular architecture than longer peptides and proteins. Its physicochemical behavior is determined mainly by its short peptide backbone, amino acid side chains, stereochemistry and ionizable groups. These characteristics influence molecular charge, polarity, flexibility, and behavior under different laboratory conditions.

Certificates:

04

Mechanism of Action Under Investigation

Published studies do not establish a specific receptor or enzyme as Pinealon’s primary molecular target. Experimental evidence instead indicates that the EDR peptide can interact directly with DNA. In cell experiments, labeled Pinealon was detected in the nucleus. while DNA-binding studies found sequence-dependent interactions with DNA. EDR was reported to partly enter the DNA major groove and interact mainly with guanine bases.

Cellular studies have also reported changes in ERK1/2 activation, reactive oxygen species and cell-cycle behavior following Pinealon exposure. A review of the experimental literature proposed that EDR may interact with nuclear components such as histones or RNA, potentially influencing gene expression and MAPK/ERK signaling. However, these proposed interactions have not established a single definitive molecular mechanism.

The available evidence therefore supports investigating Pinealon at the level of DNA interaction and intracellular signaling, Rather than a defined receptor mediated or enzyme-mediated mechanism. The precise molecular event initiating the reported cellular changes remains unresolved.

05

Scientific Research Context

Pinealon has appeared in the scientific literature as an experimental peptide investigated through laboratory and preclinical research. The available studies include cell-based experiments and animal models, with a smaller body of research involving human subjects. Research has not developed into a large or established clinical literature. Most of the available evidence therefore comes from in vitro and preclinical animal models, placing Pinealon research within an early phase of scientific investigation.

06

Pinealon Biology and Biological Pathways

01

Primary Biological Function

Published studies do not define an established physiological function for Pinealon. The biological literature instead describes several cellular processes associated with EDR peptide exposure, including regulation of cellular redox status, proliferation, and apoptosis-related activity. These observations do not support assigning Pinealon to a single established biological role.

02

Relevant Metabolic or Signaling Pathways

The main signaling pathways discussed in the Pinealon literature include MAPK/ERK signaling and pathways related to cellular redox regulation. Published work also discusses changes involving antioxidant proteins and apoptosis-associated proteins, including SOD2, GPX1, p53, and caspase-3. These pathways are relevant to the study of cellular signaling, oxidative balance, gene regulation, and programmed cell death.

03

Tissue-Specific Biology

The strongest tissue focus in the available literature is the central nervous system, particularly the cerebellum and cerebral regions. Cerebellar biology has received repeated attention, including research involving neuronal oxidative regulation. Other published work has examined neurochemical changes within the brain and cerebral cortex. The literature therefore places greater emphasis on neural tissues than on peripheral tissues.

04

Experimental Biomarkers

Reported biological markers include reactive oxygen species, ERK1/2, SOD2, GPX1, caspase-3, p53 and cell-cycle parameters. These markers represent different biological processes rather than a single Pinealon-specific pathway. Their measurement allows researchers to distinguish changes in redox regulation, intracellular signaling, apoptosis-related activity, protein expression, and cellular proliferation.

05

Laboratory Investigation Methods

The published Pinealon literature uses biochemical, cellular, molecular, and neurochemical measurements to examine these biological processes. Reported approaches include assessment of intracellular reactive oxygen species, protein and enzyme activity, cell-cycle parameters, caspase-3, and ERK1/2. Molecular studies have also examined gene-expression and protein-regulation patterns associated with EDR peptide exposure.

07

Experimental Models Used in Published Research

Published Pinealon research includes cell cultures, primary neuronal cultures, organotypic tissue cultures, and rodent models. The models range from isolated cells to intact animals. Their main limitations relate to the simplified conditions of cell and tissue cultures and the species differences that affect interpretation of findings from rodents.

01

Cell Cultures

Pinealon has been studied in PC12 cells and neutrophils. These isolated-cell systems do not reproduce intact tissue architecture, systemic regulation, or interactions between different cell populations. PC12 cells are also derived from a rat pheochromocytoma, which limits their representation of normal human cells.

02

Primary Neuronal Cultures

Primary cerebellar neuronal cultures have been used in Pinealon research. Their main limitation is the absence of intact neural architecture and connections with other brain regions. Cultured neurons also do not reproduce the vascular, endocrine, and systemic environment of the intact nervous system.

03

Organotypic Tissue Cultures

Organotypic rat pineal-gland cultures have included Glu-Asp-Arg (Pinealon) in published experiments. Although tissue organization is retained, the preparation remains outside the intact organism and lacks normal circulation and whole-body regulation.

04

Rodent Models

Pinealon has been investigated in rat models, including aged rats and prenatal experimental models. These systems retain whole-organism physiology, but differences between rats and humans in metabolism, development, and nervous-system biology limit direct translation to humans.

08

Pinealon Published Research

01

Cellular Stress and Cell Regulation

Pinealon has been investigated in relation to oxidative stress, reactive oxygen species, cell viability, necrotic cell death, and cell-cycle regulation. Research has also examined changes in ERK1/2 activity associated with Pinealon exposure.

02

Neural Function and Aging

Pinealon research has examined age-related changes in neuronal function and the regulation of proteins associated with neuronal maintenance. Published work has also investigated antioxidant enzyme synthesis, apoptosis-related proteins, serotonin-related gene expression and changes in neuronal structures associated with aging and neurodegenerative processes.

03

Hypoxic Stress

Research on Pinealon has examined its effects in hypoxic stress, including hypobaric hypoxia and prenatal hypoxia. Studies have also explored changes in antioxidant enzyme activity, oxidative stress, neuronal responses, and neurochemical processes associated with reduced oxygen availability.

04

Gene Expression and DNA Interactions

Molecular studies have investigated Pinealon-related gene expression and peptide–DNA interactions. Published work has examined the relationship of EDR with gene regulation, protein synthesis and interactions with DNA and nuclear components.

05

Neurodegeneration-Related Research

Pinealon has also been examined in research concerning Alzheimer’s and Huntington’s disease-related cellular processes. Investigations have included neuronal changes, dendritic structures, apoptosis-related proteins and antioxidant-related proteins in experimental neurodegeneration research.

09

Limitations of Current Research

01

Evidence Is Predominantly Preclinical

Pinealon has been studied in both laboratory and human research. However, much of the published work remains preclinical, particularly the research on cellular and molecular effects. This makes it difficult to draw broad conclusions from the experimental literature alone.

02

Human Clinical Evidence

Human studies of Pinealon are limited. Some published studies included older adults or other human groups, but Pinealon was sometimes studied as part of broader peptide-based approaches. This makes it harder to separate Pinealon-specific observations from the effects of the wider intervention.

03

Species Differences

Animal research forms an important part of the Pinealon literature. Differences between rodents and humans in physiology, metabolism, and brain biology limit direct comparison. Results observed in animals therefore cannot be assumed to occur in humans in the same way.

04

Study Design Limitations

Published studies use different designs, research conditions, and peptide combinations. Some human studies also examined Pinealon together with other peptides. These differences make studies difficult to compare and can limit conclusions about Pinealon alone.

05

Independent Replication

The Pinealon literature remains relatively small, and several publications come from closely related research groups. More independent studies would help determine whether the reported observations can be reproduced under different research conditions.

06

Long-Term Evidence

Long-term human research involving Pinealon has been reported, but the evidence is limited and does not provide a broad picture of Pinealon-specific long-term effects. Much of the experimental literature involves shorter studies or preclinical work.

10

Analytical Documentation

HPLC can be used to assess peptide purity and separate related substances. LC-MS can support confirmation of peptide identity through molecular-mass measurement. These methods are useful for checking the chemical quality of a research sample.

NMR has been used directly in published Pinealon research. A study of Glu-Asp-Arg examined its interaction with DNA using NMR together with other physicochemical methods.

A Certificate of Analysis (CoA) records test results for a specific batch, including applicable identity and purity measurements. Analytical documentation helps confirm that the material matches its stated chemical characteristics. It verifies product identity and quality rather than biological performance.

11

Storage and Laboratory Handling

Handle Pinealon in a clean laboratory environment with appropriate precautions to avoid contamination. Qualified personnel should keep the material properly sealed and labeled when it is not being handled.

Store Pinealon from Direct Sarms Latvia at 2–8°C according to the product specifications. Limit unnecessary exposure to heat, moisture, and other unsuitable conditions during storage. Pinealon is intended for laboratory research use only.

12

Frequently asked questions

Pinealon is a synthetic tripeptide composed of three amino acids: glutamic acid, aspartic acid, and arginine. Its sequence is Glu-Asp-Arg (EDR). It is classified as a short regulatory peptide and is also referred to in the literature as EDR peptide.
13

Why choose us?

Direct SARMs Latvia is an established supplier of research peptides. We are committed to product quality, reliable service, and helpful customer support.

Our European-made products undergo rigorous purity testing, with clear product information provided for each research material. We also aim to provide dependable shipping and a smooth ordering experience.

Our support team is available to assist with orders, shipping, payments, and general questions. At Direct SARMs Latvia, we aim to make the research supply process simple, clear, and reliable.

Pinealon Peptide is supplied solely for laboratory research and analytical purposes. It is not intended for human or veterinary use, consumption, diagnosis, treatment, or any clinical application. Information provided on this page is for scientific reference only and should be considered alongside the cited primary literature and relevant analytical documentation.
Available now

Pinealon Peptide from Direct Sarms Latvia

Pinealon Peptide Vial
20mg
Price range: $60.51 through $71.74View